- Peter Kinder resigns federal agency post, concludes position unnecessary and waste of tax dollars (6/16/18)2
- Committee to start planning process for indoor aquatic center in Cape (6/20/18)1
- Longtime downtown Cape bartender Marcellus Jones remembered by friends (6/12/18)2
- Judge denies order of protection for woman accusing deputy of stalking her (6/23/18)5
- Southeast to spend $150,000 to refresh brand with Ohio firm (6/19/18)6
- A community rallies behind Honorable Young Men's Club (6/16/18)1
- Stormy Daniels to visit East Cape Girardeau (6/13/18)20
- Jackson natives compete in 260-mile canoe race (6/16/18)1
- Mother, child reportedly hit by car in Cape Girardeau (6/18/18)
- The collateral damage of Mizzou's past failures (6/20/18)6
South Korean firm delivers commercial canine clones
SEOUL, South Korea -- Booger is back.
An American woman received five puppies Tuesday that were cloned from her beloved late pit bull, becoming the inaugural customer of a South Korean company that says it is the world's first successful commercial canine cloning service.
Seoul-based RNL Bio said the clones of Bernann McKinney's dog Booger were born last week after being cloned in cooperation with a team of Seoul National University scientists who created the world's first cloned dog in 2005.
"It's a miracle!" McKinney repeatedly shouted Tuesday when she saw the cloned Boogers for which she paid $50,000.
"Yes, I know you! You know me, too!" McKinney said joyfully, hugging the puppies, which were sleeping with one of their two surrogate mothers, both Korean mixed breed dogs.
The team of scientists working for RNL Bio is headed by Lee Byeong-chun, a former colleague of disgraced scientist Hwang Woo-suk, who scandalized the international scientific community when his purported breakthroughs in cloned stem cells were revealed as fake in 2005.
Independent tests confirmed the 2005 dog cloning was genuine, and Lee's team has since cloned more than 20 canines.
But RNL Bio said that its cloning was the first successful commercial cloning of a canine.
"RNL Bio is commencing its worldwide services with Booger as its first successful clone," the company said in a statement.
McKinney contacted Lee after Booger died of cancer in April 2006. She had earlier asked U.S.-based Genetics Savings and Clone to clone her dog but the company shut down due to lack of demand in late 2006 after only producing a handful of cloned cats and failing to produce any dog clones.
The Korean scientists brought the dog's frozen cells to Seoul in March and nurtured them before launching formal cloning work in late May, according to RNL Bio.
Lee's team have identified the puppies as Booger's genuine clones, and his university's forensic medicine team is currently conducting reconfirmation tests.
McKinney said she was especially attached to Booger because he saved her life when she was attacked by another dog three times his size. The incident resulted in her left hand being severely injured, and also damaged her leg nerves and stomach. Doctors later reconstructed her hand and she spent part of her recovery in a wheelchair.
McKinney, a screenwriter who taught drama at U.S. universities, said she will take three of the cloned dogs to her home in California and donate the others to work as service dogs for the handicapped or elderly. She said she lives with five other dogs and three horses.
RNL Bio charges up to $150,000 for dog cloning but will receive just a third of that sum from McKinney because she is the first customer and helped with publicity, said company head Ra Jeong-chan.